logo
episode-header-image
Jan 2023
21m 28s

Stem Cell Research in Multiple Sclerosis

The European Committee for Treatment and Research in Multiple Sclerosis
About this episode

Tomas Kalincik, Head of the Clinical Outcomes Research Unit at the University of Melbourne, explains his research comparing hematopoietic stem cell transplantation (HSCT) with existing treatments in relapsing and progressive MS

Up next
Sep 10
The Blood–Brain Barrier in Multiple Sclerosis: From Dysfunction to Treatment
The blood–brain barrier is a highly specialised interface that regulates the movement of cells, molecules and nutrients between the circulation and the central nervous system. But what happens when this critical barrier becomes dysfunctional in multiple sclerosis? In this episode ... Show More
25m 42s
Aug 27
Predicting MS: Can Data Bring Us Closer to Personalised Care?
Can growing amounts of real-world MS data help clinicians predict disease progression and make more personalised treatment decisions? In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Dr. Will Brown from Cambridge University and Dr. Carmen Tur from CEMCAT ab ... Show More
31m 2s
Aug 12
How Technology Is Transforming Multiple Sclerosis Care
Technology is opening new possibilities for how multiple sclerosis is monitored, treated and managed. In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Ellen Mowry of Johns Hopkins University and Prof. Letizia Leocani of Vita-Salute San Raffaele Univer ... Show More
31m 6s
Recommended Episodes
Mar 2023
Hematopoietic Stem Cell Transplant in Secondary Progressive MS
tail spinning
21m 54s
Mar 2023
MS Talks 2.0: Chasing A Cure For MS Using Stem Cells
This is MS Talks 2.0, Let’s Discuss Facts,a series brought to you by Novartis. Multiple sclerosis is an incurable disease.And if you receive a diagnosis, there can be a tendency to seek different approaches such as stem cell therapy, in search of an elusive cure.In this episode, ... Show More
11m 21s
Nov 2024
Explainer - how you can help research stem cell therapy for blood cancer
An interview with Dr Chloe Anthias, medical director of the new Cell Collection Centre has just opened by Anthony Nolan charity as part of our NIHR Nottingham Clinical Research Facility. Links a little while ago I talked to Prof Mark Bishton, who’s an oncologist at the hospital a ... Show More
14m 31s
Jun 2022
Personalized Medicine for MS
With over 20 options, what is the best multiple sclerosis treatment for me? Selecting an appropriate disease-modifying therapy (DMT) needs to consider your risk of worsening disability over time. Your age, sex and race can affect your prognosis and can influence the power of trea ... Show More
35m 41s
Mar 2023
MS Talks 2.0. Chasing A Cure: Natural Remedies
Some people believe that natural remedies could help cure Multiple Sclerosis, as opposed to traditional medication. To give us a better insight into the science and to debunk myths, we’re joined by the director of the Neurology Institute, at Harley Street Medical Center in Abu Dh ... Show More
13m 26s
Aug 2023
MRI in MS: From Pixels to Progress
Step into the powerful realm of MRI imaging, providing us with an unparalleled view of multiple sclerosis. Discover how acute inflammation becomes vivid with contrast, and how various MRI sequences unveil the past battles fought within your brain and spinal cord. We'll explore ad ... Show More
33m 33s
Sep 2025
Repairing MS: The Quest to Rebuild Myelin
The quest to repair the damage caused by multiple sclerosis is gaining momentum, with scientists working to restore lost function and slow progression by rebuilding myelin—the protective coating of nerve cells. Within the brain and spinal cord, immature myelin-making cells called ... Show More
39m 30s
Oct 2025
Reengineering Hope: CAR-T Therapy for Multiple Sclerosis
CAR-T therapy, short for chimeric antigen receptor T-cell therapy, is already transforming treatment for blood cancers like lymphoma and leukemia and is now being tested in early trials for multiple sclerosis. In this approach, a person's own T cells (or sometimes donor T cells) ... Show More
44m 8s
Mar 2024
Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Dr. Shuvro Roy talks with Dr. Annette Langer-Gould about the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Read the related article in Neurology: Neuroimmunology ... Show More
24m 12s